Accuray, Inc. (NASDAQ:ARAY)

CAPS Rating: 4 out of 5

The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.

Recs

0
Player Avatar mizims (33.24) Submitted: 12/8/2009 2:45:29 AM : Underperform Start Price: $5.29 ARAY Score: +3.47

dog

Report this Post 1 Comment
Member Avatar ssbb123 (53.09) Submitted: 2/23/2010 2:59:38 PM
Recs: 1

You picked this as an outperform in 6/09 it lost about a quarter of its value from that time to December so now its a "dog".
Yet it has regained every bit of that 25% and is an excellent long term buy and hold, probably will be on the same lines as ISRG within the next decade.
Don't put something down just because you haven't got the patience to see it through.

Report this Post

Featured Broker Partners


Advertisement